vs
ICU MEDICAL INC（ICUI）与KADANT INC（KAI）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是KADANT INC的2.0倍（$540.7M vs $271.6M），KADANT INC净利率更高（10.2% vs -2.9%，领先13.1%），KADANT INC同比增速更快（-0.0% vs -14.1%），KADANT INC自由现金流更多（$44.1M vs $36.0M），过去两年KADANT INC的营收复合增速更高（6.7% vs -2.3%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
Kadant Inc.创立于1991年，最初是Thermo Electron的子公司，部分股权私有、部分公开交易，2001年完成完全分拆并启用现名。公司服务于造纸、废纸回收、木材加工、物料搬运等多个加工领域，是业务覆盖亚洲、欧洲、北美、南美的跨国企业。
ICUI vs KAI — 直观对比
营收规模更大
ICUI
是对方的2.0倍
$271.6M
营收增速更快
KAI
高出14.1%
-14.1%
净利率更高
KAI
高出13.1%
-2.9%
自由现金流更多
KAI
多$8.1M
$36.0M
两年增速更快
KAI
近两年复合增速
-2.3%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $271.6M |
| 净利润 | $-15.7M | $27.7M |
| 毛利率 | 37.5% | 45.2% |
| 营业利润率 | 1.0% | 15.7% |
| 净利率 | -2.9% | 10.2% |
| 营收同比 | -14.1% | -0.0% |
| 净利润同比 | 34.0% | -12.2% |
| 每股收益（稀释后） | $-0.63 | $2.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUIKAI
| Q4 25 | $540.7M | — | ||
| Q3 25 | $537.0M | $271.6M | ||
| Q2 25 | $548.9M | $255.3M | ||
| Q1 25 | $604.7M | $239.2M | ||
| Q4 24 | $629.8M | $258.0M | ||
| Q3 24 | $589.1M | $271.6M | ||
| Q2 24 | $596.5M | $274.8M | ||
| Q1 24 | $566.7M | $249.0M |
净利润ICUIKAI
| Q4 25 | $-15.7M | — | ||
| Q3 25 | $-3.4M | $27.7M | ||
| Q2 25 | $35.3M | $26.2M | ||
| Q1 25 | $-15.5M | $24.1M | ||
| Q4 24 | $-23.8M | $24.0M | ||
| Q3 24 | $-33.0M | $31.6M | ||
| Q2 24 | $-21.4M | $31.3M | ||
| Q1 24 | $-39.5M | $24.7M |
毛利率ICUIKAI
| Q4 25 | 37.5% | — | ||
| Q3 25 | 37.4% | 45.2% | ||
| Q2 25 | 37.9% | 45.9% | ||
| Q1 25 | 34.7% | 46.1% | ||
| Q4 24 | 36.1% | 43.4% | ||
| Q3 24 | 34.8% | 44.7% | ||
| Q2 24 | 34.8% | 44.4% | ||
| Q1 24 | 32.7% | 44.6% |
营业利润率ICUIKAI
| Q4 25 | 1.0% | — | ||
| Q3 25 | 2.6% | 15.7% | ||
| Q2 25 | 1.9% | 15.4% | ||
| Q1 25 | 2.1% | 14.9% | ||
| Q4 24 | 6.0% | 14.3% | ||
| Q3 24 | 1.4% | 18.0% | ||
| Q2 24 | 1.3% | 17.6% | ||
| Q1 24 | -1.9% | 14.8% |
净利率ICUIKAI
| Q4 25 | -2.9% | — | ||
| Q3 25 | -0.6% | 10.2% | ||
| Q2 25 | 6.4% | 10.2% | ||
| Q1 25 | -2.6% | 10.1% | ||
| Q4 24 | -3.8% | 9.3% | ||
| Q3 24 | -5.6% | 11.6% | ||
| Q2 24 | -3.6% | 11.4% | ||
| Q1 24 | -7.0% | 9.9% |
每股收益（稀释后）ICUIKAI
| Q4 25 | $-0.63 | — | ||
| Q3 25 | $-0.14 | $2.35 | ||
| Q2 25 | $1.43 | $2.22 | ||
| Q1 25 | $-0.63 | $2.04 | ||
| Q4 24 | $-0.97 | $2.04 | ||
| Q3 24 | $-1.35 | $2.68 | ||
| Q2 24 | $-0.88 | $2.66 | ||
| Q1 24 | $-1.63 | $2.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $124.5M |
| 总债务越低越好 | — | $254.6M |
| 股东权益账面价值 | $2.1B | $949.8M |
| 总资产 | $4.1B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资ICUIKAI
| Q4 25 | — | — | ||
| Q3 25 | — | $124.5M | ||
| Q2 25 | — | $95.3M | ||
| Q1 25 | — | $91.7M | ||
| Q4 24 | $308.6M | $94.7M | ||
| Q3 24 | $312.5M | $88.4M | ||
| Q2 24 | $302.6M | $73.8M | ||
| Q1 24 | $251.4M | $81.4M |
总债务ICUIKAI
| Q4 25 | — | — | ||
| Q3 25 | — | $254.6M | ||
| Q2 25 | — | $245.7M | ||
| Q1 25 | — | $273.5M | ||
| Q4 24 | — | $285.2M | ||
| Q3 24 | — | $323.2M | ||
| Q2 24 | — | $342.0M | ||
| Q1 24 | — | $306.8M |
股东权益ICUIKAI
| Q4 25 | $2.1B | — | ||
| Q3 25 | $2.1B | $949.8M | ||
| Q2 25 | $2.1B | $926.0M | ||
| Q1 25 | $2.0B | $876.0M | ||
| Q4 24 | $2.0B | $847.1M | ||
| Q3 24 | $2.0B | $851.7M | ||
| Q2 24 | $2.0B | $807.7M | ||
| Q1 24 | $2.1B | $782.7M |
总资产ICUIKAI
| Q4 25 | $4.1B | — | ||
| Q3 25 | $4.1B | $1.5B | ||
| Q2 25 | $4.1B | $1.5B | ||
| Q1 25 | $4.2B | $1.4B | ||
| Q4 24 | $4.2B | $1.4B | ||
| Q3 24 | $4.3B | $1.5B | ||
| Q2 24 | $4.3B | $1.5B | ||
| Q1 24 | $4.3B | $1.4B |
负债/权益比ICUIKAI
| Q4 25 | — | — | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.31× | ||
| Q4 24 | — | 0.34× | ||
| Q3 24 | — | 0.38× | ||
| Q2 24 | — | 0.42× | ||
| Q1 24 | — | 0.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $47.3M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $44.1M |
| 自由现金流率自由现金流/营收 | 6.6% | 16.2% |
| 资本支出强度资本支出/营收 | 4.6% | 1.2% |
| 现金转化率经营现金流/净利润 | — | 1.70× |
| 过去12个月自由现金流最近4个季度 | $91.8M | $145.9M |
8季度趋势，按日历期对齐
经营现金流ICUIKAI
| Q4 25 | $60.6M | — | ||
| Q3 25 | $56.7M | $47.3M | ||
| Q2 25 | $11.2M | $40.5M | ||
| Q1 25 | $51.3M | $22.8M | ||
| Q4 24 | $40.2M | $51.9M | ||
| Q3 24 | $36.1M | $52.5M | ||
| Q2 24 | $82.0M | $28.1M | ||
| Q1 24 | $45.8M | $22.8M |
自由现金流ICUIKAI
| Q4 25 | $36.0M | — | ||
| Q3 25 | $27.6M | $44.1M | ||
| Q2 25 | $-8.5M | $36.5M | ||
| Q1 25 | $36.7M | $19.0M | ||
| Q4 24 | $16.1M | $46.3M | ||
| Q3 24 | $16.2M | $48.3M | ||
| Q2 24 | $62.5M | $23.1M | ||
| Q1 24 | $29.9M | $16.6M |
自由现金流率ICUIKAI
| Q4 25 | 6.6% | — | ||
| Q3 25 | 5.1% | 16.2% | ||
| Q2 25 | -1.5% | 14.3% | ||
| Q1 25 | 6.1% | 7.9% | ||
| Q4 24 | 2.6% | 17.9% | ||
| Q3 24 | 2.7% | 17.8% | ||
| Q2 24 | 10.5% | 8.4% | ||
| Q1 24 | 5.3% | 6.7% |
资本支出强度ICUIKAI
| Q4 25 | 4.6% | — | ||
| Q3 25 | 5.4% | 1.2% | ||
| Q2 25 | 3.6% | 1.6% | ||
| Q1 25 | 2.4% | 1.6% | ||
| Q4 24 | 3.8% | 2.2% | ||
| Q3 24 | 3.4% | 1.5% | ||
| Q2 24 | 3.3% | 1.8% | ||
| Q1 24 | 2.8% | 2.5% |
现金转化率ICUIKAI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | 0.32× | 1.55× | ||
| Q1 25 | — | 0.95× | ||
| Q4 24 | — | 2.16× | ||
| Q3 24 | — | 1.66× | ||
| Q2 24 | — | 0.90× | ||
| Q1 24 | — | 0.92× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
KAI
| Flow Control | $94.8M | 35% |
| Capital | $83.2M | 31% |
| Material Handling Systems | $70.3M | 26% |
| Transferred Over Time | $17.1M | 6% |
| Other | $6.1M | 2% |
